The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
EFFECTOR THERAPEUTICS INC COM 28202V108 3,889 6,822,114 SH   SOLE   6,822,114 0 0
DESIGN THERAPEUTICS INC COM 25056L103 94,075 5,626,476 SH   SOLE   5,626,476 0 0
ARCELLX INC. COMMON STOCK 03940C100 103,235 5,500,007 SH   SOLE   5,500,007 0 0
NKARTA INC. COM 65487U108 17,547 1,333,333 SH   SOLE   1,333,333 0 0